GRAIL (GRAL) Competitors $44.85 -1.87 (-4.00%) Closing price 04:00 PM EasternExtended Trading$44.60 -0.25 (-0.55%) As of 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GRAL vs. GH, OPCH, RDNT, BTSG, SHC, SGRY, CON, PRVA, WGS, and VCYTShould you be buying GRAIL stock or one of its competitors? The main competitors of GRAIL include Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), GeneDx (WGS), and Veracyte (VCYT). These companies are all part of the "healthcare" industry. GRAIL vs. Its Competitors Guardant Health Option Care Health RadNet BrightSpring Health Services Sotera Health Surgery Partners Concentra Group Holdings Parent Privia Health Group GeneDx Veracyte Guardant Health (NASDAQ:GH) and GRAIL (NASDAQ:GRAL) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends. Do insiders and institutionals hold more shares of GH or GRAL? 92.6% of Guardant Health shares are held by institutional investors. 6.1% of Guardant Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Is GH or GRAL more profitable? Guardant Health has a net margin of -53.82% compared to GRAIL's net margin of -1,464.53%. Guardant Health's return on equity of 0.00% beat GRAIL's return on equity.Company Net Margins Return on Equity Return on Assets Guardant Health-53.82% N/A -26.77% GRAIL -1,464.53%-17.99%-15.02% Do analysts rate GH or GRAL? Guardant Health presently has a consensus target price of $53.76, suggesting a potential upside of 8.52%. GRAIL has a consensus target price of $31.50, suggesting a potential downside of 29.77%. Given Guardant Health's stronger consensus rating and higher possible upside, analysts clearly believe Guardant Health is more favorable than GRAIL.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Guardant Health 0 Sell rating(s) 0 Hold rating(s) 21 Buy rating(s) 0 Strong Buy rating(s) 3.00GRAIL 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25 Does the media favor GH or GRAL? In the previous week, Guardant Health had 1 more articles in the media than GRAIL. MarketBeat recorded 12 mentions for Guardant Health and 11 mentions for GRAIL. Guardant Health's average media sentiment score of 0.74 beat GRAIL's score of 0.44 indicating that Guardant Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 5 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive GRAIL 5 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Which has higher earnings & valuation, GH or GRAL? Guardant Health has higher revenue and earnings than GRAIL. Guardant Health is trading at a lower price-to-earnings ratio than GRAIL, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGuardant Health$739.02M8.30-$436.37M-$3.39-14.61GRAIL$125.60M12.84-$2.03B-$60.99-0.74 SummaryGuardant Health beats GRAIL on 12 of the 15 factors compared between the two stocks. Get GRAIL News Delivered to You Automatically Sign up to receive the latest news and ratings for GRAL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GRAL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GRAL vs. The Competition Export to ExcelMetricGRAILMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.68B$2.92B$5.53B$9.03BDividend YieldN/A2.44%5.24%4.07%P/E Ratio-0.7420.3027.1920.03Price / Sales12.84251.54414.39108.98Price / Cash1.6241.7026.2128.59Price / Book0.607.397.925.55Net Income-$2.03B-$55.04M$3.17B$248.49M7 Day Performance-12.78%3.01%2.18%5.37%1 Month Performance16.92%-0.21%1.25%6.63%1 Year PerformanceN/A4.48%33.90%21.20% GRAIL Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GRALGRAIL0.6424 of 5 stars$44.85-4.0%$31.50-29.8%N/A$1.68B$125.60M-0.741,360Positive NewsGHGuardant Health3.7985 of 5 stars$52.04+2.3%$53.76+3.3%+74.8%$6.30B$739.02M-15.352,021OPCHOption Care Health4.3321 of 5 stars$32.48+0.7%$35.50+9.3%+12.4%$5.28B$5.00B26.198,088Positive NewsRDNTRadNet4.1986 of 5 stars$56.91-0.4%$69.60+22.3%-5.8%$4.29B$1.83B-132.3511,021News CoveragePositive NewsBTSGBrightSpring Health Services1.4019 of 5 stars$23.59+0.2%$24.90+5.6%+98.5%$4.14B$11.27B84.2535,000Analyst UpgradeSHCSotera Health3.5825 of 5 stars$11.12-1.8%$16.00+43.9%0.0%$3.21B$1.10B139.023,000SGRYSurgery Partners2.5437 of 5 stars$22.23+1.3%$33.56+50.9%-5.4%$2.81B$3.11B-14.5315,000CONConcentra Group Holdings Parent3.1487 of 5 stars$20.59-2.6%$28.50+38.4%N/A$2.71B$1.90B15.3711,250PRVAPrivia Health Group4.3278 of 5 stars$23.00+4.5%$27.77+20.7%+29.4%$2.68B$1.74B191.681,140Positive NewsHigh Trading VolumeWGSGeneDx2.1666 of 5 stars$92.31+1.3%$90.13-2.4%+216.9%$2.60B$305.45M-65.471,200Analyst UpgradeGap UpVCYTVeracyte3.751 of 5 stars$27.03-1.3%$40.90+51.3%+27.8%$2.14B$445.76M65.93790Positive News Related Companies and Tools Related Companies Guardant Health Alternatives Option Care Health Alternatives RadNet Alternatives BrightSpring Health Services Alternatives Sotera Health Alternatives Surgery Partners Alternatives Concentra Group Holdings Parent Alternatives Privia Health Group Alternatives GeneDx Alternatives Veracyte Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GRAL) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GRAIL, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GRAIL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
